In the late stages of cancer, TGF-β signaling increases the expression of mesenchymal markers N-cadherin and vimentin and downregulates the epithelial marker E-cadherin to promote EMT in tumor cells by mediating SMAD [47]. Here, VIM is linked to cancer.